| scholarly article | Q13442814 |
| P2093 | author name string | Schreiber A | |
| Thilmann AF | |||
| Konietzko N | |||
| Teschler H | |||
| Wang YM | |||
| Wessendorf TE | |||
| P2860 | cites work | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors | Q48434703 | ||
| Sleep-disordered breathing among patients with first-ever stroke | Q48729312 | ||
| Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack | Q48731769 | ||
| The effect of psychosocial stress and risk factors for ischaemic heart disease on the plasma fibrinogen concentration | Q48866640 | ||
| Investigating the relationship between stroke and obstructive sleep apnea. | Q49105399 | ||
| Sleep-disordered breathing and poor functional outcome after stroke | Q49157537 | ||
| Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. | Q50993854 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obstructive sleep apnea | Q16606552 |
| P304 | page(s) | 2039-2042 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Fibrinogen levels and obstructive sleep apnea in ischemic stroke | |
| P478 | volume | 162 |
| Q48544900 | Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk |
| Q47294246 | Association Between Hypercoagulability and Severe Obstructive Sleep Apnea. |
| Q44305061 | Association between serum fetuin-A levels, carotid artery stiffness, and intima-media thickness in patients with normotensive obstructive sleep apnea syndrome |
| Q48507311 | Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure |
| Q48225058 | Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients |
| Q40648263 | Association of sleep apnea and sleep duration with peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q48034209 | Atrial Fibrillation Is Associated With Increased Mean Platelet Volume and Apnea Hypopnea Index in Patients With Obstructive Sleep Apnea |
| Q34697950 | Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives |
| Q47915996 | Can upper airway surgery for OSA protect against cardiovascular sequelae via effects on coagulation? |
| Q47814806 | Capnography screening for sleep apnea in patients with acute stroke |
| Q61454624 | Cardiac rhythm disorders in obstructive sleep apnea |
| Q48144388 | Cardiac, lung, and brain thrombosis in a child with obstructive sleep apnea |
| Q35151651 | Cardiovascular consequences of obstructive sleep apnea |
| Q48275734 | Cardiovascular consequences of sleep apnea |
| Q36533107 | Cerebrovascular diseases and sleep-disordered breathing |
| Q47929676 | Chronic intermittent hypoxia versus continuous hypoxia: Same effects on hemorheology? |
| Q34032289 | Chronic sleep deprivation markedly reduces coagulation factor VII expression |
| Q48411115 | Clinical and societal consequences of obstructive sleep apnea and excessive daytime sleepiness |
| Q48196404 | Clinical characteristics of obstructive sleep apnea syndrome in heart transplant recipients. |
| Q26830210 | Coagulability in obstructive sleep apnea |
| Q33700780 | Day/Night rhythm of hemostatic factors in obstructive sleep apnea |
| Q44416934 | Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients |
| Q48616765 | Endothelial Function in Obstructive Sleep Apnea and Response to Treatment |
| Q35995356 | Endothelial dysfunction in obstructive sleep apnea. |
| Q30419870 | Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disorders |
| Q38613265 | Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities |
| Q53193465 | Fibrinogen Reduction and Motor Function Improvement by Hematopoietic Growth Factor Treatment in Chronic Stroke in Aged Mice: A Treatment Frequency Study. |
| Q48207950 | Fibrinogen may mediate the association between long sleep duration and coronary heart disease |
| Q48708439 | Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk |
| Q36436224 | Fibrinolytic activity and platelet function in subjects with obstructive sleep apnoea and a patent foramen ovale: is there an option for prevention of ischaemic stroke? |
| Q48438000 | Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea |
| Q48436905 | Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease? |
| Q47763274 | Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims |
| Q33984737 | Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? |
| Q36662363 | Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. |
| Q48632985 | Intestinal malabsorption as a manifestation of obstructive sleep apnea |
| Q34251014 | Mean platelet volume in patients with obstructive sleep apnea and its relationship with simpler heart rate derivatives |
| Q38739054 | Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia |
| Q39218158 | Neurological Deficits in Obstructive Sleep Apnea |
| Q38815677 | OSA and Cardiac Arrhythmogenesis: Mechanistic Insights. |
| Q35623024 | Obesity and obstructive sleep apnea |
| Q38676267 | Obstructive Sleep Apnea and Smoking as a Risk Factor for Venous Thromboembolism Events: Review of the Literature on the Common Pathophysiological Mechanisms. |
| Q35125691 | Obstructive sleep apnea and cardiovascular disease |
| Q37148717 | Obstructive sleep apnea in ischemic stroke patients |
| Q38053120 | Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis |
| Q37077161 | Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension |
| Q35781139 | Obstructive sleep apnoea and stroke |
| Q46727564 | Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children |
| Q30440658 | Pathophysiology of sleep apnea |
| Q46710321 | Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension |
| Q48538277 | Platelet function (measured by Platelet Function Analyser--100) and obstructive sleep apnoea |
| Q96817791 | Position of the hyoid bone and its correlation with airway dimensions in different classes of skeletal malocclusion using cone-beam computed tomography |
| Q48437057 | Positional sleep apnea in patients with ischemic stroke |
| Q37377506 | Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease? |
| Q44385114 | Risk of post-tonsillectomy hemorrhage by clinical diagnosis |
| Q37234496 | Self-reported snoring frequency and incidence of cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). |
| Q35258706 | Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients |
| Q55026575 | Sleep Disturbances as a Risk Factor for Stroke. |
| Q36645393 | Sleep and the metabolic syndrome |
| Q44301944 | Sleep apnea and stroke: Lifting the veil of cardiac hemodynamics during sleep |
| Q57809800 | Sleep disorders in primary antiphospholipid syndrome |
| Q24642197 | Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort |
| Q33745728 | Sleep duration, snoring habits and risk of acute myocardial infarction in China population: results of the INTERHEART study |
| Q34172154 | Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study |
| Q73512084 | Sleep-disordered breathing and stroke |
| Q48232644 | Sleep-disordered breathing in acute ischemic stroke and transient ischemic attack: effects on short- and long-term outcome and efficacy of treatment with continuous positive airways pressure--rationale and design of the SAS CARE study |
| Q34435272 | Sleep-disordered breathing, control of breathing, respiratory muscles, pulmonary function testing, nitric oxide, and bronchoscopy in AJRCCM 2000. |
| Q35866708 | Sleep-disordered breathing: implications in cerebrovascular disease |
| Q48393758 | Sleep-related breathing disorders in acute lacunar stroke. |
| Q37351255 | The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility. |
| Q37810419 | The Relationship between Sleep Disorders and Stroke |
| Q46162109 | Upper-Airway Collapsibility and Loop Gain Predict the Response to Oral Appliance Therapy in Patients with Obstructive Sleep Apnea. |
| Q55020001 | [Cardiovascular risk and obstructive sleep apnea]. |
| Q75243806 | [Sleep-disordered breathing and cerebrovascular disease] |
Search more.